Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
7.2M
-
Shares change
-
+7.2M
-
Total reported value, excl. options
-
$77.5M
-
Value change
-
+$77.5M
-
Put/Call ratio
-
0.57
-
Number of buys
-
31
-
Price
-
$11.61
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q3 2021
45 filings reported holding HUMA - Humacyte, Inc. - COM as of Q3 2021.
Humacyte, Inc. - COM (HUMA) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.2M shares
.
Largest 10 shareholders include York Capital Management Global Advisors, LLC (2.29M shares), ORBIMED ADVISORS LLC (1.5M shares), Diameter Capital Partners LP (954K shares), Monashee Investment Management LLC (750K shares), Maven Securities LTD (500K shares), CVI Holdings, LLC (500K shares), VANGUARD GROUP INC (290K shares), LPL Financial LLC (115K shares), MORGAN STANLEY (72.3K shares), and GEODE CAPITAL MANAGEMENT, LLC (30.9K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.